Editorial Comment to p21‐activated kinase 1 predicts recurrence and survival in patients with non‐metastatic clear cell renal cell carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1442-2042|22|5|453-454

ISSN： 0919-8172

Source： INTERNATIONAL JOURNAL OF UROLOGY, Vol.22, Iss.5, 2015-05, pp. : 453-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p21‐activated kinase 1 predicts recurrence and survival in patients with non‐metastatic clear cell renal cell carcinoma

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 447-453

John Wiley & Sons Inc

Access to resources Recommend Favorite

Geriatric Nutrition Risk Index is an Important Predictor of Cancer-Specific Survival, but not Recurrence-Free Survival, in Patients Undergoing Surgical Resection for Non-Metastatic Renal Cell Carcinoma

By  

Current Urology, Vol. 10, Iss. 1, 2017-03 ,pp. : 26-31

Karger

Access to resources Recommend Favorite

Computerized Tomography Measurement of Visceral Adiposity Predicts Plasma Adiponectin Levels and Metastatic Disease in Patients with Clear Cell Renal Cell Carcinoma

By  

Current Urology, Vol. 2, Iss. 4, 2009-02 ,pp. : 188-193

Karger

Access to resources Recommend Favorite

The Impact of the Preoperative Serum Albumin Level and Postoperative C-Reactive Protein Nadir on the Survival of Patients with Non-Metastatic Renal Cell Carcinoma with Vessel Thrombus after Nephrectomy

By  

Current Urology, Vol. 5, Iss. 4, 2011-12 ,pp. : 190-195

Karger

Access to resources Recommend Favorite

Editorial Comment to Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 6, 2015-06 ,pp. : 540-540

John Wiley & Sons Inc

Access to resources Recommend Favorite